• Technical Guide: HyperPFU™ High-Fidelity DNA Polymerase in P

  2026-05-20

  HyperPFU™ high-fidelity DNA polymerase addresses the need for robust, accurate PCR amplification of long or GC-rich DNA templates where standard polymerases often fail due to low fidelity or processivity. It is best applied to workflows requiring blunt-ended, high-fidelity products, but not for protocols needing 3'-A overhangs or sticky ends.

• Capsaicin: Mechanistic Powerhouse for Translational Pain Res

  2026-05-20

  Explore how (E)-Capsaicin—a dual TRPV1 activator and KDM1A/LSD1 inhibitor—redefines the landscape of translational research in pain, inflammation, and cancer. This article integrates mechanistic insights, data-driven protocols, and strategic guidance for researchers aiming to bridge the gap from bench to bedside, while highlighting competitive context and future directions.

• Cisplatin (A8321): Breakthroughs in Chemosensitivity and EMT

  2026-05-19

  Explore the multifaceted role of Cisplatin in cancer research, focusing on its mechanisms, experimental best practices, and new insights into chemosensitivity and EMT modulation. This article examines cutting-edge findings that distinguish Cisplatin applications and optimize apoptosis and chemoresistance studies.

• Ruthenium Red: Precision Ca2+ Transport Inhibitor for Autoph

  2026-05-19

  Ruthenium Red is a gold-standard Ca2+ transport inhibitor that enables precise dissection of cytoskeleton-dependent calcium signaling and autophagy. This guide delivers actionable protocols, troubleshooting strategies, and translational insights from the latest mechanotransduction research, supporting reproducible success in advanced cell signaling studies.

• Nonivamide (Capsaicin Analog): TRPV1 Agonism in Cancer and I

  2026-05-18

  Explore how Nonivamide, a capsaicin analog, enables precise TRPV1 modulation for both cancer growth inhibition and inflammation control. This article uniquely bridges molecular mechanism, in vivo efficacy, and protocol strategy for advanced research.

• Lanabecestat (AZD3293): Reliable BACE1 Inhibition in AD Rese

  2026-05-18

  This article provides a scenario-driven, evidence-based exploration of Lanabecestat (AZD3293), SKU BA8438, for Alzheimer's disease research. It addresses real laboratory challenges in amyloid-beta production inhibition, experimental design, and product selection, guiding researchers toward reproducible and synaptic-sparing protocols. Direct comparisons and protocol recommendations highlight Lanabecestat's validated performance.

• Nonivamide: A Capsaicin Analog for Cancer and Inflammation M

  2026-05-17

  Nonivamide, a potent capsaicin analog, empowers researchers to selectively activate TRPV1 pathways for targeted cancer cell inhibition and neuroimmune modulation. With robust evidence for both anti-proliferative and anti-inflammatory actions, it offers reproducible workflows and troubleshooting insights for translational studies.

• PEO Chain Density Modulates Uremic Toxin Adsorption Dynamics

  2026-05-16

  This study dissects how end-tethered methoxy-PEO (m-PEO) chain density on gold surfaces influences the adsorption of clinically relevant uremic toxins, including 4-ethylphenyl sulfate. By integrating surface characterization and targeted LC/MS analytics, the research advances understanding of biomaterial–toxin interactions critical for renal and gut-brain axis research.

• Ceftolozane-Tazobactam in Nosocomial Pneumonia: Structural a

  2026-05-15

  The reference study elucidates the molecular and pharmacological innovations of ceftolozane-tazobactam in treating nosocomial pneumonia, especially its efficacy against multidrug-resistant Pseudomonas aeruginosa. By dissecting structure–activity relationships and clinical outcomes, the paper guides researchers in designing infection models and benchmarking alternative cephalosporins.

• Pterostilbene Protects the BBB in Ischemic Stroke via Cytosk

  2026-05-15

  This study demonstrates that pterostilbene, a natural compound found in blueberries and grapes, confers neuroprotection in cerebral ischemia/reperfusion (I/R) injury by stabilizing the blood–brain barrier (BBB). The work uncovers dual-stage mechanisms: early cytoskeletal stabilization and late Wnt pathway activation, providing insight into multi-target strategies for stroke therapy.

• Capsaicin: TRPV1 Activation and KDM1A Inhibition in Research

  2026-05-14

  Capsaicin ((E)-Capsaicin) is a dual-acting compound that activates TRPV1 ion channels and inhibits KDM1A/LSD1. Its roles span pain, itch, and cancer models. APExBIO's C6366 product provides high purity, validated for mechanistic and translational research.

• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-05-14

  Capsazepine from APExBIO empowers researchers to dissect TRPV1-mediated nociception and apoptosis mechanisms with nanomolar potency and workflow flexibility. Learn how to optimize experimental protocols, troubleshoot common challenges, and leverage recent cross-domain insights for robust pain and cancer research outcomes.

• Metronidazole: OAT3 Inhibition & Antibiotic Benchmarking

  2026-05-13

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) is a nitroimidazole antibiotic and potent OAT3 inhibitor. It offers high-purity, reproducible inhibition for research on anaerobic bacteria and protozoa. APExBIO’s validated product enables reliable modulation of drug transport and interaction studies.

• Caspofungin in Translational Candida Research: Mechanisms &

  2026-05-13

  A deep-dive for translational researchers into the mechanistic, experimental, and strategic considerations when leveraging Caspofungin—a lipopeptide antifungal drug targeting β-(1,3)-D-glucan biosynthesis—in the fight against azole-resistant Candida. This thought-leadership piece blends biological insight with protocol guidance, competitive context, and forward-looking analysis, building upon recent experimental findings and APExBIO’s product excellence.

• TRPV1+ Nerve Stimulation Suppresses Inflammation via Neuroim

  2026-05-12

  Song et al. (2025) uncover a somato-autonomic neural circuit where stimulation of TRPV1+ peripheral sensory nerves at the nape rapidly suppresses systemic inflammation through catecholamine secretion and splenic gene modulation. This work provides mechanistic insight into non-pharmacological anti-inflammatory strategies that target neuroimmune interactions.

14665 records 1/978 page Next 12345 下5页 Last page